The Biologics in Canada series examines Canadian and international trends in the sales, cost, use, and pricing of biologics as of the end of 2018, highlighting the significant potential savings that could be achieved if biosimilar uptake and pricing levels in Canada were brought closer in line with international levels.

ORGANIZATION:

RESOURCE TYPE:
REPORT

Skills